Literature DB >> 1800442

A new method of estimating prevalence of injecting drug use in an urban population: results from a Scottish city.

M Frischer1, M Bloor, A Finlay, D Goldberg, S Green, S Haw, N McKeganey, S Platt.   

Abstract

Using modelling techniques derived from behavioural ecology, unnamed identifier data from a variety of partial samples of injecting drug users [IUDs] were used to estimate the prevalence of this population in Glasgow during 1989. The model yielded an estimate of 9424 [95% confidence interval +/- 2460] which represents a prevalence rate of 15 per 1000 population aged 15-55. The estimated male:female ratio was 2.64:1 and the modal IDU aged 20-24. These figures should facilitate assessment of the service requirements of this group and provide a basis from which the number of IDUs infected with HIV and the number likely to progress to AIDS can be determined. As the methodology required to facilitate reliable prevalence estimates utilizes relatively easy to obtain information it could be repeated in other urban centres where drug injecting is known to occur.

Entities:  

Mesh:

Year:  1991        PMID: 1800442     DOI: 10.1093/ije/20.4.997

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  11 in total

1.  Female streetworking prostitution and HIV infection in Glasgow.

Authors:  N McKeganey; M Barnard; A Leyland; I Coote; E Follet
Journal:  BMJ       Date:  1992-10-03

2.  Counting the uncatchable? An epidemiological method for counting drug misusers.

Authors:  S Cox; M Shipley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-01       Impact factor: 4.328

3.  Mortality among injecting drug users: a critical reappraisal.

Authors:  M Frischer; M Bloor; D Goldberg; J Clark; S Green; N McKeganey
Journal:  J Epidemiol Community Health       Date:  1993-02       Impact factor: 3.710

4.  Longitudinal and cross sectional mortality studies in injecting drug-users.

Authors:  M Davoli; F Forastiere; D D Abeni; E Rapiti; C A Perucci
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

5.  A decline in the prevalence of injecting drug users in Estonia, 2005-2009.

Authors:  Anneli Uusküla; Kristiina Rajaleid; Ave Talu; Katri Abel-Ollo; Don C Des Jarlais
Journal:  Int J Drug Policy       Date:  2013-01-03

6.  Capture-recapture methods to size alcohol related problems in a population.

Authors:  G Corrao; V Bagnardi; G Vittadini; S Favilli
Journal:  J Epidemiol Community Health       Date:  2000-08       Impact factor: 3.710

7.  An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men.

Authors:  Spencer Lieb; Samuel R Friedman; Mary Beth Zeni; Dale D Chitwood; Thomas M Liberti; Gary J Gates; Lisa R Metsch; Lorene M Maddox; Tamara Kuper
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

8.  Insulin dependent diabetes in children under 5: incidence and ascertainment validation for 1992.

Authors:  E Wadsworth; J Shield; L Hunt; D Baum
Journal:  BMJ       Date:  1995-03-18

9.  Estimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method.

Authors:  T D Mastro; D Kitayaporn; B G Weniger; S Vanichseni; V Laosunthorn; T Uneklabh; C Uneklabh; K Choopanya; K Limpakarnjanarat
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

10.  Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Authors:  Lucas Wiessing; Marica Ferri; Vendula Běláčková; Patrizia Carrieri; Samuel R Friedman; Cinta Folch; Kate Dolan; Brian Galvin; Peter Vickerman; Jeffrey V Lazarus; Viktor Mravčík; Mirjam Kretzschmar; Vana Sypsa; Ana Sarasa-Renedo; Anneli Uusküla; Dimitrios Paraskevis; Luis Mendão; Diana Rossi; Nadine van Gelder; Luke Mitcheson; Letizia Paoli; Cristina Diaz Gomez; Maitena Milhet; Nicoleta Dascalu; Jonathan Knight; Gordon Hay; Eleni Kalamara; Roland Simon; Catherine Comiskey; Carla Rossi; Paul Griffiths
Journal:  Harm Reduct J       Date:  2017-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.